FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308102701> ?p ?o ?g. }

• W4308102701 endingPage "e002445" @default.
• W4308102701 startingPage "e002445" @default.
• W4308102701 abstract "Objective To explore the risk of pre-eclampsia in rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA), focusing on the impact of treatment and disease activity. Methods We identified RA, AxSpA and PsA singleton pregnancies (2006–2018) by linking medical birth registers to Swedish (SRQ) and Danish (DANBIO) rheumatology registers. Control pregnancies from the medical birth registers were matched 1:10 on maternal age, parity and birth year. We obtained information on antirheumatic treatment before and during pregnancy and disease activity during pregnancy. Risks of pre-eclampsia in RA, AxSpA and PsA pregnancies, compared with control pregnancies, were estimated overall and by antirheumatic treatment (conventional synthetic disease-modifying antirheumatic drug (DMARD)/biological DMARD/corticosteroids, as monotherapy or combination therapy) and disease load (Health Assessment Questionnaire≥1/C-reactive protein≥10/Disease Activity Score in 28 joints≥3.2) through logistic regression (adjusted ORs (aORs) with 95% CI). Results We observed 69, 34, and 26 pre-eclampsia events among RA (n=1739), AxSpA (n=819) and PsA (n=489), resulting in a risk of pre-eclampsia of, respectively, aOR 1.27 (95% CI 0.96 to 1.67), 1.17 (0.76 to 1.78) and 1.85 (1.10 to 3.12), compared with controls. For RA, maternal combination therapy before and during pregnancy was associated with increased risk (1.59; 1.07 to 2.37 and 1.53; 0.97 to 2.39, respectively). For PsA, maternal monotherapy before pregnancy was associated with pre-eclampsia (2.72; 1.4 to 5.13). In RA pregnancies with available information (43%), high disease load was associated with doubled risk of pre-eclampsia (aOR 1.96; 1.26 to 3.04). Conclusion PsA pregnancies, but not AxSpA pregnancies, were at increased risk of pre-eclampsia. For RA, combination therapy (potentially a surrogate for high disease activity both before and during pregnancy) and high disease load during pregnancy might be a risk factor for pre-eclampsia." @default.
• W4308102701 created "2022-11-08" @default.
• W4308102701 creator A5004806882 @default.
• W4308102701 creator A5017582190 @default.
• W4308102701 creator A5017765516 @default.
• W4308102701 creator A5033617928 @default.
• W4308102701 creator A5063586848 @default.
• W4308102701 creator A5078386764 @default.
• W4308102701 date "2022-11-01" @default.
• W4308102701 modified "2023-10-15" @default.
• W4308102701 title "Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark" @default.
• W4308102701 cites W1483655797 @default.
• W4308102701 cites W1495532091 @default.
• W4308102701 cites W1576249624 @default.
• W4308102701 cites W180581279 @default.
• W4308102701 cites W1976566530 @default.
• W4308102701 cites W1978670003 @default.
• W4308102701 cites W2056106279 @default.
• W4308102701 cites W2066074894 @default.
• W4308102701 cites W2073862617 @default.
• W4308102701 cites W2080276371 @default.
• W4308102701 cites W2084765163 @default.
• W4308102701 cites W2110680652 @default.
• W4308102701 cites W2117451838 @default.
• W4308102701 cites W2133542467 @default.
• W4308102701 cites W2146035399 @default.
• W4308102701 cites W2146210453 @default.
• W4308102701 cites W2160002020 @default.
• W4308102701 cites W2166018731 @default.
• W4308102701 cites W2168021466 @default.
• W4308102701 cites W2202897015 @default.
• W4308102701 cites W2219591537 @default.
• W4308102701 cites W2233885014 @default.
• W4308102701 cites W2324859219 @default.
• W4308102701 cites W2541013163 @default.
• W4308102701 cites W2543221315 @default.
• W4308102701 cites W2739862510 @default.
• W4308102701 cites W2754813187 @default.
• W4308102701 cites W2789473281 @default.
• W4308102701 cites W2790411350 @default.
• W4308102701 cites W2794698944 @default.
• W4308102701 cites W2797497810 @default.
• W4308102701 cites W2891000078 @default.
• W4308102701 cites W2915532856 @default.
• W4308102701 cites W2944003670 @default.
• W4308102701 cites W2949382697 @default.
• W4308102701 cites W2960659672 @default.
• W4308102701 cites W2965140615 @default.
• W4308102701 cites W2991098154 @default.
• W4308102701 cites W3124321717 @default.
• W4308102701 cites W3154926220 @default.
• W4308102701 cites W3158913701 @default.
• W4308102701 cites W3163897246 @default.
• W4308102701 cites W4200380568 @default.
• W4308102701 cites W4206739528 @default.
• W4308102701 cites W4211203631 @default.
• W4308102701 cites W4290851564 @default.
• W4308102701 doi "https://doi.org/10.1136/rmdopen-2022-002445" @default.
• W4308102701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36328400" @default.
• W4308102701 hasPublicationYear "2022" @default.
• W4308102701 type Work @default.
• W4308102701 citedByCount "2" @default.
• W4308102701 countsByYear W43081027012023 @default.
• W4308102701 crossrefType "journal-article" @default.
• W4308102701 hasAuthorship W4308102701A5004806882 @default.
• W4308102701 hasAuthorship W4308102701A5017582190 @default.
• W4308102701 hasAuthorship W4308102701A5017765516 @default.
• W4308102701 hasAuthorship W4308102701A5033617928 @default.
• W4308102701 hasAuthorship W4308102701A5063586848 @default.
• W4308102701 hasAuthorship W4308102701A5078386764 @default.
• W4308102701 hasBestOaLocation W43081027011 @default.
• W4308102701 hasConcept C126322002 @default.
• W4308102701 hasConcept C131872663 @default.
• W4308102701 hasConcept C1862650 @default.
• W4308102701 hasConcept C198451711 @default.
• W4308102701 hasConcept C2776260265 @default.
• W4308102701 hasConcept C2777575956 @default.
• W4308102701 hasConcept C2779234561 @default.
• W4308102701 hasConcept C2781276381 @default.
• W4308102701 hasConcept C2908564923 @default.
• W4308102701 hasConcept C2909063479 @default.
• W4308102701 hasConcept C54355233 @default.
• W4308102701 hasConcept C71924100 @default.
• W4308102701 hasConcept C86803240 @default.
• W4308102701 hasConceptScore W4308102701C126322002 @default.
• W4308102701 hasConceptScore W4308102701C131872663 @default.
• W4308102701 hasConceptScore W4308102701C1862650 @default.
• W4308102701 hasConceptScore W4308102701C198451711 @default.
• W4308102701 hasConceptScore W4308102701C2776260265 @default.
• W4308102701 hasConceptScore W4308102701C2777575956 @default.
• W4308102701 hasConceptScore W4308102701C2779234561 @default.
• W4308102701 hasConceptScore W4308102701C2781276381 @default.
• W4308102701 hasConceptScore W4308102701C2908564923 @default.
• W4308102701 hasConceptScore W4308102701C2909063479 @default.
• W4308102701 hasConceptScore W4308102701C54355233 @default.
• W4308102701 hasConceptScore W4308102701C71924100 @default.
• W4308102701 hasConceptScore W4308102701C86803240 @default.
• W4308102701 hasFunder F4320310460 @default.

• next